PALVELLA THERAPEUTICS, INC. ($PVLA)
Filing Information
| Accession Number | 0001104659-26-044895 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 17, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
12,906
Total Value
$582,282.38
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Common Stock | โ | Apr 15, 2026 | Exercise/Conversion | 2,154 | $7.14 | $15,379.56 | 2,154 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Apr 15, 2026 | Exercise/Conversion | 2,148 | $9.08 | $19,503.84 | 4,302 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Apr 15, 2026 | Sale | 1,502 | $125.96 | $189,198.98 | 2,800 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Apr 15, 2026 | Sale | 1,500 | $127.13 | $190,688.10 | 1,300 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Apr 15, 2026 | Sale | 561 | $128.23 | $71,939.78 | 739 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Apr 15, 2026 | Sale | 639 | $129.17 | $82,539.12 | 100 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Apr 15, 2026 | Sale | 100 | $130.33 | $13,033.00 | 0 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | Apr 15, 2026 | Exercise/Conversion | 2,154 | $0.00 | $0.00 | 12,935 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | Apr 15, 2026 | Exercise/Conversion | 2,148 | $0.00 | $0.00 | 12,888 | Direct | โ | View Details |